OrbitoAsia Diagnostics

Adenosine Deaminase (ADA) - Pleural Fluid


Adenosine Deaminase (ADA) is a type of enzyme that is present in large amounts within certain white blood cells known as lymphocytes. A pleural effusion refers to the unusual buildup of fluid in the area between the lungs and the chest wall. The ADA – Adenosine Deaminase – Pleural Fluid test is used to determine the ADA concentration in pleural fluid. A high ADA concentration in pleural fluid might indicate tuberculosis (TB) affecting the pleura (the lung’s lining). This test is performed to aid in the diagnosis of pleural TB. Nonetheless, it’s crucial to recognize that a high ADA concentration in pleural fluid might also be a result of other health issues, including rheumatoid arthritis, systemic lupus erythematosus (SLE), and certain forms of cancer.

Frequently Asked Questions

The ADA (Adenosine Deaminase) test measures the level of adenosine deaminase enzyme activity in pleural fluid. It's primarily used to help diagnose pleural tuberculosis (TB) and distinguish it from other causes of pleural effusion, such as cancer or bacterial infections. Elevated ADA levels in pleural fluid are indicative of TB infection.

The ADA (Adenosine Deaminase) test on pleural fluid is performed primarily to aid in the diagnosis of pleural tuberculosis (TB). It helps distinguish TB from other causes of pleural effusion, such as cancer or bacterial infections. Elevated levels of ADA in pleural fluid are suggestive of TB infection, assisting healthcare providers in making accurate diagnoses and initiating appropriate treatment.

The ADA (Adenosine Deaminase) test on pleural fluid is typically recommended when tuberculosis (TB) is suspected as a cause of pleural effusion. It's especially relevant in regions where TB is prevalent or in individuals with risk factors for TB infection. Healthcare providers may order this test for patients presenting with symptoms suggestive of TB, such as persistent cough, fever, night sweats, and weight loss, along with evidence of pleural effusion on imaging studies.

If the results of the ADA (Adenosine Deaminase) test on pleural fluid are abnormal, with elevated levels of ADA, it suggests the possibility of pleural tuberculosis (TB). In such cases, further evaluation, including chest imaging studies (such as chest X-ray or CT scan) and microbiological tests (such as sputum culture or TB DNA tests), may be necessary to confirm the diagnosis of TB. Treatment for TB, typically involving a combination of antibiotics known as anti-tuberculosis drugs, would then be initiated promptly.

During the ADA (Adenosine Deaminase) test on pleural fluid, a sample of pleural fluid is collected from the patient using a procedure called thoracentesis. The patient typically sits upright or lies on their side while a healthcare provider inserts a thin needle through the chest wall into the pleural space to withdraw fluid.

Once the fluid is obtained, it is sent to a laboratory for analysis. In the lab, the level of ADA enzyme activity in the pleural fluid sample is measured. The test results are then reported to the healthcare provider, who interprets them in the context of the patient's clinical presentation and other diagnostic findings to determine the presence or absence of pleural tuberculosis.

Why OrbitoAsia Diagnostics?

Orbito Asia Labs and Scans is a comprehensive healthcare imaging and diagnostic facility under one roof. It prides itself on providing the most advanced infrastructure, the best possible medical facilities, the most competitive prices, and thorough individualised attention so that the customer can have diagnostic tests performed in the most efficient and cost-effective manner at a single location by our experienced and certified physicians and friendly staff.

We are committed to providing our clients with ultimate diagnostic services with accurate results, high-quality imaging, and comprehensive health check-up services with comprehensive care, courtesy, and compassion for our clients. Orbito Asia provides diagnostic solutions that improve patient health and ensure consumer safety.